Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Source
BDPM_FR
(
ARTG
)
PAZOPANIB ADVZ is indicated for the treatment of:
Advanced and/or metastatic renal cell carcinoma (RCC).
Advanced (unresectable and/or metastatic) soft tissue sarcoma (STS) in patients who, unless otherwise contraindicated, have received prior chemotherapy including an anthracycline treatment.,The Phase III trial population excluded patients with gastrointestinal stromal tumour (GIST) or adipocytic soft tissue sarcoma.
PillsCard reference image